Navigation Links
FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
Date:8/13/2008

- Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1

and Hepatitis C, on Fully and Semi-Automated Instrument Systems -

SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration (FDA) has approved its supplemental regulatory application to use the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV). The FDA had previously approved the assay to screen donated blood for HIV-1 and the hepatitis C virus (HCV).

The assay is now approved to screen donated blood, plasma, organs and tissue for the three viruses in individual blood donations or in pools of up to 16 blood samples. The assay may be run on the enhanced semi-automated PROCLEIX system (eSAS) and on the fully automated, high-throughput PROCLEIX TIGRIS(R) system.

"Gaining full FDA approval of the PROCLEIX ULTRIO assay is an important milestone for our blood screening business," said Hank Nordhoff, Gen-Probe's chairman and chief executive officer. "More importantly, demonstrating that the assay intercepts HBV-infected blood donations that older tests miss is an important scientific finding that may help further safeguard the US blood supply. We are grateful to the blood screening centers that participated in the trials to demonstrate the utility of the assay." The PROCLEIX ULTRIO assay is manufactured by Gen-Probe and sold worldwide by Chiron, a Novartis business.

Based on the full approval of the PROCLEIX ULTRIO assay on the TIGRIS system, Gen-Probe expects to record a $10 million milestone payment from Chiron as collaborative research revenue in its third-quarter financial results.

Background

In October of 200
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
2. US FDA Grants Pediatric Exclusivity for UCBs Keppra(R)
3. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
4. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
5. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
6. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
7. Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
8. European Union, State of Brandenburg, Award Grants to Alcat Europe, GmbH
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
11. United States Patent Office Grants CryoCors Request for Patent Interference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wswire/ -- Biopharmaceutical company Kiadis,Pharma... enrolled in its,multinational registration clinic...how reduction in transplant related mortality (TRM... transplantation with a mismatched,(haplo-identica...allogeneic,stem cell transplantation but without h...
(Date:11/30/2009)...e-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasd... Administration (FDA) has granted orphan drug desi...ridine phosphate, for the rare autoimmune disease ... has previously received orphan drug designation i...or Medicinal Products for Human Use of the Europea...
(Date:11/30/2009)...swire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a,le...evice research and,development outsourcing company...nnounced that it had been selected to the Deloitte...consecutive year. The list recognizes the 50,faste... and telecommunications,industries based on revenu...
(Date:11/28/2009)...l Advisory Committee on Climate Change (NACCC) thr...ct in collaboration with the Vanuatu Meteorologica...e generated preliminary climate change and sea lev...the country’s SNC reporting to the United Na...CC). , Port Vila, Vanuat...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...n Investment to Finance Growth in Chindex,s Health...ina, BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ --...ding independent American provider of Western,heal...lic of China, today,announced that it has agreed t... Management group. The investment will consist of ...
...., Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: ...Transgenomic Inc. Third Quarter 2007 Earnings Rele...ay, November 7, 2007 @ 5:00 p.m. Eastern, Where: ... How: Live over the Internet -- Simply log on...tact: Investor Relations -- 402-452-5400 To acce...
... CA, Nov. 7 /PRNewswire-FirstCall/ - Nventa,Biopha...y financial results,for the third quarter ended Se...herwise, are in Canadian dollars. Nventa reported...r the,three months ended September 30, 2007, compa...are, for the same period in 2006. For the nine,mon...
Other Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
(Date:11/30/2009)...port published in the December 2009 print issue of...r type of control over their fertility that women ...s have found how and where androgenic hormones wor... and male fertility. This opens a promising avenue...scovery also offers hope to those who cannot have ...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2New stem cell identification technology could cure breast cancer 4969 1New stem cell identification technology could cure breast cancer 4969 2First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 1ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 3
...eir kind, researchers at Rice University and The U...ve determined that carbon nanotubes injected direc...ause no immediate adverse health effects and circu...d by the liver. , The findings are from the first ...on nanotubes, a revolutionary nanomaterial that ma...
...scoveries are named Charlotte, but they are weavin...studies at Texas A&M University have led to th... one species found for the first time in Texas. , ...dation, Henderson, who is earning a master,s degre...ribution and abundance in the 515-acre Lick Creek ...
... of Warwick should have gardeners and commercial g...ic waste composts. The University,s plant research... paper based composts are proving to be a major we...s. , A University of Warwick research team under ...use of composts can reduce the incidence of some i...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2Recycled paper and compost could both be key tools to control plant disease 2
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: